What is Telemedi?
Telemedi, headquartered in Warsaw, Poland, offers a sophisticated and user-friendly telemedical platform designed to connect patients with doctors across various specialties through internet or telephone consultations. The company aims to modernize healthcare access by providing convenient and efficient remote medical services. Its technology addresses the growing demand for accessible healthcare solutions, positioning Telemedi as a key player in the digital health transformation.
How much funding has Telemedi raised?
Telemedi has raised a total of $6.6M across 1 funding round:
Series A
$6.6M
Series A (2021): $6.6M with participation from Adamed, PKO VC, UNIQA Ventures, Flashpoint, and Black Pearls VC
Key Investors in Telemedi
Flashpoint
Flashpoint Venture Capital is an international group managing equity and debt funds, investing in software companies. It provides business-to-business software-as-a-service solutions in the initial revenues.
UNIQA Ventures
UNIQA Ventures is an investment firm that likely focuses on innovative companies within the insurance and broader financial technology sectors, providing strategic backing for growth.
Black Pearls VC
Black Pearls VC is a venture capital firm that specializes in investing in early-stage technology companies, particularly those with disruptive potential in their respective markets.
What's next for Telemedi?
The recent major strategic investment signifies a strong vote of confidence in Telemedi's business model and future prospects. This capital will likely be deployed to further develop its platform technology, expand its network of medical professionals, and enhance its market reach. As Telemedi continues to scale, it is poised to capitalize on the increasing adoption of telemedicine, potentially leading to further rounds of financing or strategic partnerships to solidify its position in the competitive health-tech landscape.
See full Telemedi company page
